Biopharmas in Asia-Pacific raising money in public or private financings: Salubris, Shenzhen Salubris.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Airos Medical, Happiest Baby, Sanara Medtech.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aurora Spine, Biologica, Biovica, Bioviiix, Boston Scientific, Calyx, Cardiovascular Systems, Endotronix, Innovia Medical, Inverness Graham, IT health Fusion, PHC Corp., Northwell Health, Novascan, Royal Philips, Shore Capital.

Med-tech firms raising money in public or private financings, including: Chitogenx, Delcath, Neuronetics, Oncocyte.

New hires and promotions in the med-tech industry, including: Dariohealth, Mend, Otonexus Medical Technologies, Sight Sciences.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alaunos, Arbutus, Arrowhead, Beactica, Biontech, Briacell, Diamyd, Enzyvant, Forcefield, Freeline, Genevant, Gri, GSK, Histogram, Indivumed, Liquidia, Medigene, Metabolon, Myovant, Oncternal, Oscotec, Pfizer, Precigen, Sumitomo, Sumitovant, Tonix, Urovant, Vallon, VBI.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abcuro, Akebia, Ascendis, Alzamed, Citius, Contrafect, Corvus, Ensysce, Fibrogen, Kodiak, Lipocine, Oncosec, Oryzon, Pardes, Scioto, Travere, Vico.

Biopharmas raising money in public or private financings, including: Cure Ventures, Diamond, Mosaic, OS Therapies, Psyence, Recce, Redhill, Viking.

New hires and promotions in the biopharma industry, including: Acasti, Aicuris, Arkuda, Biogen, Entrada, Flamingo, Legend, Mitsubishi Tanabe, Quantro.

The top 10 med-tech stock gainers and losers for the week.